<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Supp/DMAE.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:34:07 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="2838003">
<meta name="Category" content="Supp">
<meta name="Article" content="DMAE">
<title>Dimetiletanolamina-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">DMAE</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="DMAE.htm">Volver al art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Zahniser NR, Chou D, Hanin I. Is 2-dimethylaminoethanol (deanol) indeed a
precursor of brain acetylcholine? A gas chromatographic evaluation. <em>J Pharmacol Exp
Ther</em> 1977;200:545-59.</li>

<li class="Ref">Kazamatsuri H, Chien C, Cole JO. Therapeutic approaches to tardive dyskinesia.
<em>Arch Gen Psychiatry</em> 1972;27:491-9.</li>

<li class="Ref">Alphs L, Davis JM. Noncatecholaminergic treatments of tardive dyskinesia. <em>
J Clin Psychopharmacol</em> 1982;2:380-5 [review].</li>

<li class="Ref">Haug BA, Holzgraefe M. Orofacial and respiratory tardive dyskinesia: potential
side effects of 2-dimethylaminoethanol (deanol)? <em>Eur Neurol</em> 1991;31:423-5.</li>

<li class="Ref">Ferris SH, Sathananthan G, Gershon S, Clark C. Senile dementia: treatment with
deanol. <em>J Am Geriatr Soc</em> 1977;25:241-4.</li>

<li class="Ref">Fisman M, Mersky H, Helmes E. Double-blind trial of 2-dimethylaminoethanol in
Alzheimer&#8217;s disease. <em>Am J Psychiatry</em> 1981;138:970-2.</li>

<li class="Ref">Casey DE, Denney D. Dimethylaminoethanol in tardive dyskinesia. <em>N Engl J
Med</em> 1974;291:797.</li>

<li class="Ref">Fisman M, Mersky H, Helmes E. Double-blind trial of 2-dimethylaminoethanol in
Alzheimer&#8217;s disease. <em>Am J Psychiatry</em> 1981;138:970&#8211;2.</li>

<li class="Ref">Sergio W. Use of DMAE (2-dimethylaminoethanol) in the induction of lucid
dreams. <em>Med Hypotheses</em> 1988;26:255&#8211;7.</li>

<li class="Ref">Casey DE. Mood alterations during deanol therapy. <em>Psychopharmacology</em>
1979;62:187&#8211;91.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Supp/DMAE.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:34:07 GMT -->
</html>

